Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer
972.9500 -5.50 (-0.56%)
NSE Jul 10, 2025 15:31 PM
Volume: 721.7K
 

972.95
-0.56%
ICICI Securities Limited
Zydus Lifesciences’ (Zydus) Q4FY25 revenue gained with healthy traction in US (+20%), domestic branded formulation (+10.7%) and its consumer business (+17.1%).
Zydus Lifesciences L.. has an average target of 1024.00 from 6 brokers.
More from Zydus Lifesciences Ltd.
Recommended